Abstract
Dermal substitutes have been widely used as therapeutic options in skin damage to regenerate the skin. Rapid vascularization of a dermal substitute can provide channels for nutritional support, excretion and create an interventional pathway for the immune system during the early wound healing stages. Therefore it is important to evaluate the vascularization property of dermal substitutes in the process of dermal reconstruction. In this study, a proangiogenic self-assembling peptide nanofiber hydrogel (SLg) was synthesized and combined with UV-cured gelatin (GelMA) to prepare a series of three-dimensional (3D) printed scaffolds. Interpenetrating polymer networks (IPNs) comprising interwoven gelatin and peptide were constructed during 3D printing process, resulting in advancement in absorbency and elasticity. Moreover, the 3D printed GelMA/SLg scaffolds exhibited controlled porosity, pore size and connected pore properties. These properties provided the appropriate microenvironment for cellular migration, proliferation and were conducive for the growth of blood vessels leading to early angiogenesis. An in vivo study found that 3D printed GelMA/SLg scaffolds containing 20% peptide hydrogel exhibited the best collagenous fibrous structure, fastest repair cycles in revascularization and dermal regeneration. These results imply that the proangiogenic scaffold promotes early rapid vascularization and tissue healing, and is a promising therapeutic option for high-quality regenerative repair of skin damage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.